A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
about
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceChronic radiation proctitis: tricks to prevent and treatExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentClinical implementation of pharmacogeneticsData-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.Radiogenomics: radiobiology enters the era of big data and team science.Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.EPMA position paper in cancer: current overview and future perspectives.Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.Personalized radiotherapy: concepts, biomarkers and trial designCommon genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.The contribution of women to radiobiology: Marie Curie and beyondMeta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerBiomarkers in anal cancer: from biological understanding to stratified treatment.In vitro prediction of breast cancer therapy toxicity.Non-homologous end-joining protein expression screen from radiosensitive cancer patients yields a novel DNA double strand break repair phenotype.Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis.Radiogenomics and radiotherapy response modeling.Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Evidence for variation in human radiosensitivity and its potential impact on radiological protection.Genetic susceptibility to cutaneous radiation injury.Genetic predisposition to prostate cancer.TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis.Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.Genome-wide association studies of cancer: current insights and future perspectives.A review of prostate cancer genome wide association studies (GWAS).Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.The role of Next-Generation Sequencing in tumoral radiosensitivity prediction.Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
P2860
Q26778374-E5255355-D382-468A-B6C0-A36BC2B62503Q26801205-992605FF-6E61-4B9A-8BF4-FB22A794E0D7Q26849735-8D531DD9-7157-4CF0-8770-30184584EB13Q28072159-40985320-E2A6-4F19-8020-E8DD25780F0DQ30234489-0A374944-CEB9-4D1D-B87B-8989F6D7F784Q30240052-507E9FC0-23EE-402D-882F-8C5DC7623866Q30833608-5301B1F8-2DAA-4B3E-953A-E24D1618D2D3Q31116483-2CB766BA-415E-431C-B810-A2CC11E19010Q35532215-79D01E37-FED1-4DB5-8440-7CD3C5C20619Q35668905-D6F5EA81-ED20-4FA3-B963-B285E8397BD9Q35900753-8CA1C4EF-4F13-4EC5-BDF9-F268F0A8BA14Q36077772-9FEDA1E0-AB1D-4073-B81B-1537E48EAC62Q36235704-B9F7ED25-0D29-4628-9A50-CA7D4835F81FQ36898448-051BDD72-9128-48AD-BD74-BD487727089FQ37211721-D970A51B-06E6-4141-9488-B92CBB7AA2F6Q37283218-FB6AA991-6ABC-4815-94F2-09D9C39A2359Q37592879-8AE01CBD-3EE5-4F03-AA49-EF21DD3C4A43Q37714322-2D60A450-0597-4630-AC5F-5E8CD56B5622Q37714343-EF2E39A1-57C7-4614-A55A-A9EC785F67D4Q38606919-36186959-CC55-4A06-B0B2-E144B772002AQ38655709-4AB46D33-6D41-43A2-995F-E235DF001BCFQ38665620-2D8A0271-EA5B-4364-B4C8-9CE5D5C418BDQ38761174-2E61D5A3-FBE6-4341-A41D-035F97E705AAQ38766132-8C03BB2E-AF96-46A9-AEE6-134FD5E18FB8Q39017652-81E48FDE-AF4F-455E-8741-7706B5DEF85EQ39035687-80629192-60FB-495E-9B3F-09D696DE7B6DQ40996284-BAB69E47-8027-4D62-8639-6DF6A1CE0BFEQ45198533-31DE1DDA-6609-44A2-9901-BA39462C91EDQ47109602-32F206A5-78D7-4A6B-8307-9DE58522B403Q47606195-A89AD354-DCB7-47E7-A9FD-08C7DE9D2E21Q47900293-3951C6AB-A16F-40E9-92B1-C2A42DCCDB56Q48515655-B0CC570D-5AB8-45E8-B80C-C1DDF65051FDQ50491249-75C3527E-32DD-4AFD-A9D8-2FE6096B4FCCQ50562612-E141F0EC-41B4-40F8-8655-D98DAD311A7FQ52805099-D2BDB5A8-781D-42C8-9264-8549CBC11423Q55428338-AA42717B-F2B2-46EC-90CD-71242A0502DA
P2860
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@en
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@nl
type
label
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@en
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@nl
prefLabel
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@en
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
A three-stage genome-wide asso ...... diotherapy toxicity at 2q24.1.
@en
P2093
Ana M Carballo
Barry S Rosenstein
David P Dearnaley
Gillian C Barnett
Leila Dorling
Neil G Burnet
Patricia Calvo-Crespo
Paula Peleteiro
Ramón Lobato-Busto
P2860
P2888
P304
P356
10.1038/NG.3020
P407
P50
P577
2014-06-29T00:00:00Z
P6179
1043860043